Invention Grant
- Patent Title: Fused morpholinopyrimidines and methods of use thereof
-
Application No.: US15210927Application Date: 2016-07-15
-
Publication No.: US09771378B2Publication Date: 2017-09-26
- Inventor: Duane A. Burnett , Matthew Gregory Bursavich , Andrew J. McRiner
- Applicant: Denali Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: DENALI THERAPEUTICS, INC.
- Current Assignee: DENALI THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Viksins Harris Padys Malen LLP
- Main IPC: C07D498/10
- IPC: C07D498/10 ; C07D498/04 ; C07D498/20 ; A61K31/5383 ; C07D498/14
Abstract:
The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
Public/Granted literature
- US20170044182A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF Public/Granted day:2017-02-16
Information query
